Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Lawn

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Practical Neurology|October 6, 2023
Adult-onset Kufs diseaseAlbert Kelly, John Dunne, Carolyn Orr, et al.
Neurology. Clinical Practice|February 24, 2018
Neuroimaging of first-ever seizure: Contribution of MRI if CT is normalKevin Ho, Nicholas Lawn, Michael Bynevelt, et al.
Epilepsy Research|September 24, 2013
First seizure in the older patient: clinical features and prognosisNicholas Lawn, Andrew Kelly, John Dunne, et al.
Epilepsia|November 25, 2020
Starting a new anti-seizure medication in drug-resistant epilepsy: Add-on or substitute?Mubeen Janmohamed, Nicholas Lawn, Katrina Spilsbury, et al.
BMJ Neurology Open|March 8, 2021
Continuous EEG use and status epilepticus treatment in Australasia: a practice survey of Australian and New Zealand epileptologistsJoshua Laing, Nicholas Lawn, Piero Perucca, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|October 25, 2023
Continuous electroencephalography in the intensive care unit: A critical review and position statement from an Australian and New Zealand perspectiveMichaela Waak, Joshua Laing, Lakshmi Nagarajan, et al.
Epilepsy & Behavior : E&B|February 4, 2018
Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDsAndrew Neal, Wendyl D'Souza, Graham Hepworth, et al.
Epilepsy & Behavior : E&B|January 21, 2020
The other side of the leaf: Seizures associated with synthetic cannabinoid useKuhilan Gounder, Janavi Dunuwille, John Dunne, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 20, 2015
Propofol as a substitute for amobarbital in Wada testingAlbert Ho Yuen Chiu, Michael Bynevelt, Nicholas Lawn, et al.
Epilepsy & Behavior : E&B|April 28, 2022
Risk factors and consequences of self-discontinuation of treatment by patients with newly diagnosed epilepsySameer Sharma, Zhibin Chen, Maria Rychkova, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Practical Neurology|October 6, 2023
Adult-onset Kufs diseaseAlbert Kelly, John Dunne, Carolyn Orr, et al.
Neurology. Clinical Practice|February 24, 2018
Neuroimaging of first-ever seizure: Contribution of MRI if CT is normalKevin Ho, Nicholas Lawn, Michael Bynevelt, et al.
Epilepsy Research|September 24, 2013
First seizure in the older patient: clinical features and prognosisNicholas Lawn, Andrew Kelly, John Dunne, et al.
Epilepsia|November 25, 2020
Starting a new anti-seizure medication in drug-resistant epilepsy: Add-on or substitute?Mubeen Janmohamed, Nicholas Lawn, Katrina Spilsbury, et al.
BMJ Neurology Open|March 8, 2021
Continuous EEG use and status epilepticus treatment in Australasia: a practice survey of Australian and New Zealand epileptologistsJoshua Laing, Nicholas Lawn, Piero Perucca, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|October 25, 2023
Continuous electroencephalography in the intensive care unit: A critical review and position statement from an Australian and New Zealand perspectiveMichaela Waak, Joshua Laing, Lakshmi Nagarajan, et al.
Epilepsy & Behavior : E&B|February 4, 2018
Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDsAndrew Neal, Wendyl D'Souza, Graham Hepworth, et al.
Epilepsy & Behavior : E&B|January 21, 2020
The other side of the leaf: Seizures associated with synthetic cannabinoid useKuhilan Gounder, Janavi Dunuwille, John Dunne, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 20, 2015
Propofol as a substitute for amobarbital in Wada testingAlbert Ho Yuen Chiu, Michael Bynevelt, Nicholas Lawn, et al.
Epilepsy & Behavior : E&B|April 28, 2022
Risk factors and consequences of self-discontinuation of treatment by patients with newly diagnosed epilepsySameer Sharma, Zhibin Chen, Maria Rychkova, et al.
Pageof 4